Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Closure of Trading Window

 In terms of SEBI (Prohibition of Insider Trading) Regulations, 2015 and Company''s Code of Conduct to regulate, monitor and report trading by designated persons & Immediate relative of Designated Persons, Trading for dealing in securities of Jagsonpal Pharmaceuticals Limited shall remain closed with effect from Monday, July 01, 2024 till the end of 48 hours after the declaration of Unaudited financial results for quarter ended June 30, 2024.
28-06-2024
Bigul

JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

 We are Pleased to informed you that the Nomination and Remuneration Committee has issued and allotted 16,317 Equity shares of Rs. 5/- each under JPL ESOP 2022, to the eligible employee of the company.
20-06-2024
Bigul

JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Announcement under Regulation 30 (LODR)-Updates on Acquisition

 We now wish to inform you that on completion of customary conditions, the transactions has now achieved as closure.
31-05-2024
Bigul

Jagsonpal Pharma introduces new product; shares rise

 The shares were up by 4.71 per cent to 349 at 12 pm on the BSE
24-05-2024
Bigul

JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

 Please find enclosed herewith copy of press release isuued by the company titled " Jagsonpal Launched MemUp: India''s First Biodentical Hormone Replacement Therapy in a Single Pill"
24-05-2024
Bigul

JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Please find enclosed copies of advertisement published on May 22, 2024, in ''Business Standard'' (English) and ''Business Standard'' (Hindi) newspaper providing Extract of Audited Financial Results of the Company for the quarter and year ended March 31, 2024.
22-05-2024
Bigul

JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Compliances-Reg.24(A)-Annual Secretarial Compliance

 Pursuant to Regulation 24A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed Annual Secretarial Compliance Report for the Financial Year ended March 31, 2024.
21-05-2024
Bigul

JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Disclosure Of Related Party Transaction Under Regulation 23(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

 Please find enclosed related party disclosure for the half year ended October 01, 2023 to March 31, 2024
20-05-2024
Bigul

JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

 Intimation of grant of Employee Stock Options
20-05-2024
Bigul

JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Corporate Action-Board to consider Dividend

 The Board of Directors at their meeting held today have recommended dividend of Rs. 5/- (100%) per equity share of face value of Rs. 5/- for the financial year ended March 31, 2024.
20-05-2024
Next Page
Close

Let's Open Free Demat Account